Cash & equivalents decreased 44.0%
Cash & equivalents changed -44.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -44.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +36.1% from the comparable as-filed period.
Shares outstanding changed -2.2% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Net income changed +28.0% from the comparable as-filed period.
Total assets changed +29.9% from the comparable as-filed period.
Operating cash flow changed +11.9% from the comparable as-filed period.
Operating cash-flow margin changed -886 basis points from the comparable as-filed period.
Stock-based compensation changed -22.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stockholders' equity changed +2.4% from the comparable as-filed period.
SBC / revenue changed -66 basis points from the comparable as-filed period.
Operating cash flow / net income changed -12.6% from the comparable as-filed period.
Selling, general & administrative changed -2.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +71.2% from the comparable as-filed period.
Revenue changed +34.8% from the comparable as-filed period.
Net income changed +37.0% from the comparable as-filed period.
Shares outstanding changed -0.8% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Total assets changed +34.2% from the comparable as-filed period.
Operating cash-flow margin changed +1014 basis points from the comparable as-filed period.
Selling, general & administrative changed +18.9% from the comparable as-filed period.
Stock-based compensation changed +22.0% from the comparable as-filed period.
Operating cash flow / net income changed +25.0% from the comparable as-filed period.
Stockholders' equity changed +4.3% from the comparable as-filed period.
Cash & equivalents changed -1.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -11 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.